Invention Grant
- Patent Title: Hydroxybutyrate ester and medical use thereof
-
Application No.: US14101834Application Date: 2013-12-10
-
Publication No.: US10051880B2Publication Date: 2018-08-21
- Inventor: Kieran Clarke , Richard Lewis Veech
- Applicant: Isis Innovation Limited , The United States of America, as represented by the Secretary, Department of Health And Human Services
- Applicant Address: GB Oxford US DC Washington
- Assignee: OXFORD UNIVERSITY INNOVATION LIMITED,THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Current Assignee: OXFORD UNIVERSITY INNOVATION LIMITED,THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Current Assignee Address: GB Oxford US DC Washington
- Agency: Lathrop Gage LLP
- Agent Brian C. Trinque; Benjamin A. Vaughan
- Main IPC: A61K31/22
- IPC: A61K31/22 ; A23L2/52 ; C07C69/675 ; A23L33/10

Abstract:
A compound which is 3-hydroxybutyl 3-hydroxybutyrate enantiomerically enriched with respect to (3R)-hydroxybutyl (3R)-hydroxybutyrate of formula (I) is an effective and palatable precursor to the ketone body (3R)-hydroxybutyrate and may therefore be used to treat a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, for instance a condition where weight loss or weight gain is implicated, or to promote alertness or improve cognitive function, or to treat, prevent or reduce the effects of neurodegeneration, free radical toxicity, hypoxic conditions or hyperglycaemia.
Public/Granted literature
- US20140194509A1 HYDROXYBUTYRATE ESTER AND MEDICAL USE THEREOF Public/Granted day:2014-07-10
Information query